Release Date: 30/03/20 09:22 Summary: FY2019 Preliminary Financial Report and Appendix 4E Price Sensitive: Yes Download Document 402.51KB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market